News for 'research and development'

Two key drivers for stock markets this week

Two key drivers for stock markets this week

Rediff.com14 Sep 2025

Equity markets will keenly track outcome of the US Federal Reserve policy meeting this week amid heightened expectations of an interest rate cut along with WPI inflation data, analysts said. Any further development on the USndia trade front would also drive trends in the equity market, experts said.

'Bulldozer Justice Continues Despite SC Verdict'

'Bulldozer Justice Continues Despite SC Verdict'

Rediff.com2 Dec 2025

'Even as the Supreme Court's anti-punitive demolition judgment nears its first anniversary, no formal contempt proceedings have been initiated either by the Supreme Court or any high court against officers or demolition squads who have acted in violation of it.'

'Bihar Doesn't Predict Outcomes In Bengal, UP'

'Bihar Doesn't Predict Outcomes In Bengal, UP'

Rediff.com25 Nov 2025

'The question for the TMC is not whether it can hold its bastions, but whether it can expand effectively into regions where the BJP already possesses a good ecosystem.'

From 1905 cry to Modi's 'Vocal for Local': NCERT's new Swadeshi lessons

From 1905 cry to Modi's 'Vocal for Local': NCERT's new Swadeshi lessons

Rediff.com3 Oct 2025

Two modules published by the NCERT, Swadeshi: Vocal for Local (for middle stage) and Swadeshi: For a Self-Reliant India (for secondary stage), carry excerpts from the prime minister's Independence Day address in which he stressed that self-reliance would drive India's journey towards a Viksit Bharat.

AI talent demand accelerates; job postings rise 11.7% in Sep

AI talent demand accelerates; job postings rise 11.7% in Sep

Rediff.com22 Oct 2025

With demand for AI skills continuing to grow across India, a report on Wednesday showed that AI-related job postings increased to 11.7 per cent this September from 8.2 per cent in the same month a year ago. In September, 11.7 per cent of Indian job postings explicitly mentioned AI in their job descriptions, up from 10.6 per cent three months earlier and 8.2 per cent a year ago, global hiring platform Indeed said in a report.

Making Robots To Help Humanity

Making Robots To Help Humanity

Rediff.com24 Nov 2025

'Our vision is to innovate as many products as we can and solve as many problems as possible.'

How To Choose MFs Smartly

How To Choose MFs Smartly

Rediff.com3 Dec 2025

Investors who constantly hop between 'top-performing' funds often end up earning far lower returns than the very funds they invest in -- simply because they enter late and exit early. Best investors don't chase returns, they chase discipline, says Ramalingam Kalirajan.

India's Medtech Industry To Develop High-end Equipment

India's Medtech Industry To Develop High-end Equipment

Rediff.com17 Apr 2025

According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, while exports stood at $3.7 billion in the financial year 2023-24 (FY24)

Realty's Next Address: SPR, Sohna Power NCR's Growth

Realty's Next Address: SPR, Sohna Power NCR's Growth

Rediff.com18 Oct 2025

Part-I of this three-part series dives into Delhi-NCR's SPR, Sohna, Dwarka Expressway, and Jewar Airport leading the charge.

Beware Pak, China! India test fires missile 'Pralay'

Beware Pak, China! India test fires missile 'Pralay'

Rediff.com29 Jul 2025

India successfully test-fired the newly-developed tactical missile Pralay, capable of carrying conventional warheads, from APJ Abdul Kalam island off the coast of Odisha. The missile, developed by DRDO, has a range of 150 to 500 km and a payload capacity of 500-1,000 kg.

India to send man into space by 2027, land on Moon by 2040

India to send man into space by 2027, land on Moon by 2040

Rediff.com15 Oct 2025

ISRO Chairman V Narayanan announces ambitious space program goals, including landing Indians on the Moon by 2040 and launching the 'Gaganyaan' mission in 2027. The agency is also working on a national space station and uncrewed missions.

Infosys wins 14K cr deal to modernise UK's NHS workforce management system

Infosys wins 14K cr deal to modernise UK's NHS workforce management system

Rediff.com15 Oct 2025

The 15-year agreement will see Infosys develop a next-generation, data-driven workforce management platform to replace the existing electronic staff record (ESR) system, which annually manages a 55 billion payroll for 1.9 million NHS employees.

'Bihar Has Never Delivered Such A One-Sided Mandate'

'Bihar Has Never Delivered Such A One-Sided Mandate'

Rediff.com15 Nov 2025

'This outcome is thoroughly unexpected.' 'I travelled extensively across villages, engaged in detailed discussions with residents, and consulted with party workers who had been canvassing from village to village, from one location to another, seeking grassroots feedback.' 'Not a single interlocutor suggested that there would be an NDA wave of this magnitude.'

Vietnam Emerges As India's Key Defence Partner

Vietnam Emerges As India's Key Defence Partner

Rediff.com17 Nov 2025

The 15th India-Vietnam Defence Dialogue signalled a move from routine talks to deeper cooperation, with new deals on submarine rescue and defence industry to support stability in the Indo-Pacific, notes Dr Rajaram Panda.

Google plans $15 bn AI hub in Visakhapatnam

Google plans $15 bn AI hub in Visakhapatnam

Rediff.com14 Oct 2025

Google plans to invest $15 billion over the next five years in setting an artificial intelligence hub in Visakhapatnam, a senior official of the company said on Tuesday.

Factors that will guide the markets this week

Factors that will guide the markets this week

Rediff.com20 Oct 2025

Equity market investors would track global trends, foreign fund movement and quarterly earnings in a holiday-shortened week ahead, analysts said. Stock exchanges BSE and NSE will conduct a special Muhurat trading session on Tuesday, October 21.

Govt to operationalise Rs 1-trillion innovation fund in next 3 months

Govt to operationalise Rs 1-trillion innovation fund in next 3 months

Rediff.com29 May 2025

The Rs 1-trillion Research Development and Innovation (RDI) fund, which was announced in the July budget for FY25, of which Rs 20,000 crore has already been allocated, will be operationalised in the next two to three months, a top official said.

Rosatom To Expand Non-Nuclear Footprint In India

Rosatom To Expand Non-Nuclear Footprint In India

Rediff.com6 Oct 2025

Extending its nuclear power plant supply relationship with India to the non-nuclear sector, Russia's integrated atomic power major Rosatom State Corporation is in talks for a 50:50 additive technology joint venture.

In a first, Agni-Prime fired from rail-based launcher

In a first, Agni-Prime fired from rail-based launcher

Rediff.com25 Sep 2025

India successfully test fired the Agni-Prime missile from a rail-based mobile launcher. The next-generation missile has a range of up to 2,000 kilometers and advanced features.

IndiGo Tops in Flight Cancellations

IndiGo Tops in Flight Cancellations

Rediff.com5 Aug 2025

IndiGo, which operates the largest fleet among Indian carriers, has reported the highest number of serious engine-related incidents.

'Educated Youth Voted RJD, Uneducated Youth Voted JD-U'

'Educated Youth Voted RJD, Uneducated Youth Voted JD-U'

Rediff.com19 Nov 2025

'When you compare Bihar's poverty from its earlier times, then there is a huge difference. Things have improved a lot. And migration has played an important role in reducing poverty.'

'Modi Won't Risk Upsetting Nitish'

'Modi Won't Risk Upsetting Nitish'

Rediff.com15 Nov 2025

'If Nitish Kumar were to depart from this alliance, it would signal substantial instability in central government politics.'

Development potential, cash flows to ensure growth for Macrotech in FY26

Development potential, cash flows to ensure growth for Macrotech in FY26

Rediff.com9 May 2025

Macrotech Developers (Lodha), the country's second-largest listed real estate company, exceeded its 2024-25 (FY25) guidance, aided by a strong pre-sales performance in the January-March quarter (Q4), driven by launches. The company had guided for Rs 17,500 crore in pre-sales for FY25 and surpassed that with bookings of Rs 17,630 crore.

ISRO conducts first Gaganyaan parachute test

ISRO conducts first Gaganyaan parachute test

Rediff.com24 Aug 2025

ISRO successfully conducted the first Integrated Air Drop Test (IADT-01) to validate the parachute-based deceleration system for the Gaganyaan mission, demonstrating a crucial step towards India's human spaceflight program.

AI Threat: 2 Million Tech Jobs At Risk

AI Threat: 2 Million Tech Jobs At Risk

Rediff.com20 Oct 2025

To turn disruption into opportunity, NITI Aayog has recommended the launch of a National AI Talent Mission to make India the AI workforce capital of the world.

Why US-China Face-Off Is Advantage India

Why US-China Face-Off Is Advantage India

Rediff.com29 Oct 2025

Amid US-China trade tensions and economic vulnerabilities, India must seize the 'China +1' opportunity, deepen reforms, secure FTAs, and globalise its firms for long-term growth, suggests Ajay Shah.

'ISRO Will Ensure Security Of Every Citizen Of Bharat'

'ISRO Will Ensure Security Of Every Citizen Of Bharat'

Rediff.com1 Oct 2025

'You can observe a lot of things from space.' 'Another thing is communication, in real time, especially in war-like situations.' 'During Operation Sindoor, we could play our part well.'

'The Problem With Quick Fixes Is...'

'The Problem With Quick Fixes Is...'

Rediff.com8 Aug 2025

'...they always address problems superficially, never tackling root causes.' 'Currently, the policy response will focus on immediate relief -- getting people to safety, providing facilities, clearing debris.' 'This is necessary, but once immediate relief operations end, everything returns to 'normal' without addressing underlying vulnerabilities.'

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Rediff.com12 Aug 2025

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

India's Space Manufacturing Boom

India's Space Manufacturing Boom

Rediff.com15 Aug 2025

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

Covid-19: China refutes claims of 'gain-of-function' research at Wuhan lab

Covid-19: China refutes claims of 'gain-of-function' research at Wuhan lab

Rediff.com12 Feb 2025

China has firmly denied that its Wuhan Institute of Virology conducted gain-of-function studies on coronavirus, rejecting allegations that the US Agency for International Development (USAID) funded such research at the lab. The Chinese Foreign Ministry spokesperson, Guo Jiakun, emphasized that the lab has never engaged in gain-of-function research, designed, made, or leaked COVID-19. China has also reiterated its stance on the origins-tracing of COVID-19, stating that the pandemic was "extremely unlikely" to have originated from a lab leak, as concluded by the WHO-China joint mission.

India successfully tests desi integrated air defence system

India successfully tests desi integrated air defence system

Rediff.com24 Aug 2025

India has successfully conducted maiden flight tests of an integrated air defence weapon system (IADWS) off the coast of Odisha. The system includes quick reaction surface-to-air missiles, very short range air defence system (VSHORADS) missiles, and a high power laser based directed energy weapons (DEW) system.

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.

AdFalciVax Is India's Malaria Vaccine

AdFalciVax Is India's Malaria Vaccine

Rediff.com21 Jul 2025

'AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing single-stage malaria vaccines.'

Physical AI: The Next Big Leap in Manufacturing

Physical AI: The Next Big Leap in Manufacturing

Rediff.com18 Oct 2025

Physical AI equips machines with the ability to perceive, learn, and act in the real world by integrating AI algorithms with sensors and actuators in physical systems like robots and vehicles.

'Uddhav Should Not Join Hands With Raj Thackeray'

'Uddhav Should Not Join Hands With Raj Thackeray'

Rediff.com5 Nov 2025

'Raj Thackeray is working at the behest of Chief Minister Devendra Fadnavis.'

AI Mania Drives Global Markets

AI Mania Drives Global Markets

Rediff.com3 Oct 2025

'India may never fully participate in the AI hype cycle, but we can position ourselves to benefit from its inevitable disenchantment and the cycle of disillusionment,' alerts Akash Prakash.

'India will respond with full force whenever terrorism threatens citizens'

'India will respond with full force whenever terrorism threatens citizens'

Rediff.com20 Aug 2025

The Indian government outlines its futuristic defence programme, Sudarshan Chakra Mission, focusing on indigenous development, predictive technologies, and targeted counter-action systems to enhance national security.

How IoT is going to change India's audit ecosystem

How IoT is going to change India's audit ecosystem

Rediff.com12 Sep 2025

The International Organisation of Supreme Audit Institutions (INTOSAI) has adopted the 2026-28 Work Plan, which prioritises cybersecurity audits and remote audits using Internet of Things technologies, CAG said in a release on Friday. The work plan was adopted at the 34th Annual Meeting of INTOSAI Working Group on IT Audit (WGITA), which was held along with the 17th Steering Committee Meeting of the INTOSAI Knowledge Sharing Committee (KSC) in Hyderabad.

US tariffs: Only Sun Pharma exposed to some headline risk

US tariffs: Only Sun Pharma exposed to some headline risk

Rediff.com28 Sep 2025

The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report.